The global computational biology market size is expected to reach USD 13.6 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 21.3% during the forecast period. Rise in clinical studies in pharmacokinetics and pharmacogenomics for novel drug delivery and increase in the application of computational biology for bioinformatics R&D programs for the population based sequencing studies are fueling the market growth.
Rising
use of computational tools in genomics, epi-genomics, proteomics, and
meta-genomics to understand 3D protein structural analysis, protein-protein
interactions, and gene sequencing and expression studies coupled with
increasing research activities in drug designing and disease modeling is
expected to drive the growth. However, lack of skilled resources to operate
computational tools is expected to restrain the growth of the computational
biology market during the forecast period.
Many
pharmaceutical companies are seeking funding from angel investors. For
instance, in February 2019, StemoniX Inc., the U.S. based provider of product
and services for drug discovery and development, received funding of USD 14.40
million from a group of investors. Brightstone Venture Capital was the major
financer and was later joined by Crescent Ridge Partners, Alumni Ventures
Group, and Mayo Clinic. Similarly, in the same month, U.S. based Buffalo
Niagara Medical Campus received funding of USD 5.0 million to speed up the
discovery of new drugs. With this finding, the research institute is planning
to procure and install drug discovery research instruments and other drug
discovery platforms.
Full Research Report On Computational Biology Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/computational-biology-market
Further key
findings from the report suggest:
- Cellular and
biological simulation is expected to expand at the fastest CAGR of over
15.0% over the forecast period. The shift in sequencing studies towards
further analysis of the nature of various biological proteins as a part of
the development of personalized medicine, is projected drive the growth
- Drug
discovery and disease modelling applications led the market, accounting
for 38.0% of the global market in terms of revenue in 2018. The factors
responsible for this growth are extensive drug pipelines for the global
drug manufacturing firms
- North America
was the largest regional market, accounted for more than 45.0% of the
global revenue in 2018. Increase in research activities for drug discovery
processes and innovations in biological computation tools are anticipated
to drive the growth
- Asia Pacific
is anticipated to witness the fastest of around CAGR of 23.0% during the
forecast period, due to increasing expenditure in the clinical studies for
the pharmaco-kinetics and pharmaco-genomics
- Some of the
players operating in the computational biology market include Chemical
Computing Group Inc.; Compugen Ltd.; Simulation Plus Inc.; Genedata AG;
Certara; Insilico Biotechnology AG; Accelrys; Rhenovia Pharma SAS;
Entelos; Nimbus Discovery LLC; and Rhenovia Pharma SAS.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/computational-biology-market/request/rs1
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment